Aimmune Therapeutics Inc
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Aimmune Therapeutics Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Aimmune Therapeutics Inc through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
BioCryst Pharmaceuticals (BCRX) Presents At Cowen 41st Annual Healthcare Virtual Conference - Slideshow via Seeking Alpha
Amgen to buy Five Prime Therapeutics in a deal valued at $1.9 billion to boost cancer treatment portfolio via Yahoo Finance
Aimmune Therapeutics Inc Performance
Active Alerts for IEX:AIMT
You don't have any alerts set for IEX:AIMT.
About Aimmune Therapeutics Inc
Aimmune Therapeutics Inc is engaged in the field of biotechnology. It researches and develops drug candidates for the treatment of peanut and other food allergies.
Real-time AIMT to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.